To evaluate the outcomes of double lung transplants in patients with stage 4 lung cancer that has not metastasized.
Approach:
Study Design: The study followed 404 patients with end-stage pulmonary disease, including 98 with stage 4 lung cancer, comparing outcomes of 17 patients who received lung transplants to 81 patients receiving standard treatments.
Key Findings:
All 17 lung cancer transplant patients survived after one year, compared to 88% of patients transplanted without cancer.
Among the lung cancer transplant patients, there were four recurrences of cancer and two deaths unrelated to cancer.
74 out of 81 patients receiving standard care saw their cancers progress.
Interpretation:
Limitations:
The study's findings need to be confirmed in larger, randomized studies.
Ethical considerations regarding organ allocation in a zero-sum system must be addressed.
